Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hunter Group ASA - Second Quarter Results 2020

27 August 2020   Financial highlights Total revenues of USD 29.62m − Spot pool revenues of USD 14.78m − Time charter revenues of USD 14.84m Total operating expenses of USD 6.44m − Vessel opex incl. insurance of USD 2.46m − Voyage exp. and commissions of USD 0.33m − G&A expenses of 0.33m − USD 0.19m administrative expenses − USD 0.06m legal expenses − USD 0.08m non-cash expenses EBITDA of USD 26.50m Net profit of USD 18.84m   Average daily earnings of USD 76,340 − Avg. daily spot earnings of USD 75,0001 − Avg. daily time charter earnings

Positive results and stronger financial position

Summary of April – June 2020 · Net sales increased to 54.6 (20.4) MSEK, of which 33.5 MSEK derived from the Täby Turf rental project. · Net operating profit totaled 3.0 MSEK (-26.3). The West Side Solna and Metronomen co-op projects contributed 13.3 MSEK. · Cash flow from operating activities amounted to -79.3 MSEK (-34.3). The production start of the Platform West co-op project had a -75.8 MSEK impact on cash flow and the sale of half of the Älvsjö Quarters rental project had a positive impact of 33.0 MSEK. · Production started at Platform West co-op project (109 units) in

Interim report January-June 2020

Press release 27 August 2020APRIL–JUNE 2020 · Net sales amounted to MSEK 238.3 (247.3). · EBIT amounted to MSEK 30.3 (24.0). · EBIT margin amounted to 12.7% (9.7). · Net income was MSEK 18.1 (18.4). · Earnings per share, before and after dilution, amounted to SEK 1.81 (1.84). JANUARY–JUNE 2020 · Net sales amounted to MSEK 486.6 (496.1). · EBIT amounted to MSEK 49.1 (53.1). · EBIT margin amounted to 10.1% (10.7). · Net income was MSEK 32.6 (43.3). · Earnings per share, before and after dilution, amounted to SEK 3.26 (4.33). SIGNIFICANT EVENTS DURING

Panoro Energy Announces Half Year 2020 (1H) Results and Provides Operations and Corporate Updates

Oslo, 27 August 2020 - Panoro Energy (the “Company” or “Panoro” with OSE ticker: “PEN”) is pleased to announce its financial and operating results for the six months ended 30 June, 2020: John Hamilton, CEO of Panoro, commented: “Further to the decisive actions taken earlier in the year, the second quarter has seen a gradual return to a more stabilised operating environment, and in fact oil production has performed very well, with record quarterly output achieved. We are very excited by the newly reprocessed Dussafu seismic, acquired by Panoro in 2013, indicating that the Hibiscus area

Interim Report April - June

Exceptionally high sales, mainly due to Covid-19· The Group's sales during the first quarter amounted to SEK 99.5 (14.5) million. Adjusted for non-recurring sales, sales amounted to SEK 22.4 (14.5) million, an increase of 55%. · Gross profit amounted to SEK 22.4 (7.4) million for the quarter, an increase of 203%. · Operating profit for the quarter amounted to SEK 11.6 (0.08) million. · Earnings per share were SEK 0:39 (0:00) for the quarter. · Cash flow from operating activities amounted to SEK 55.9 (-2.5) million for the quarter. · Cash and cash equivalents were SEK 64.8 (15.

Nordic Nanovector ASA: Results for the Second Quarter and First Half 2020

Oslo, Norway, 27 August 2020 Nordic Nanovector ASA (OSE: NANO) announces its results for the second quarter and first half 2020. A presentation by Nordic Nanovector’s management team will take place today in Oslo at 08.30 CET, see details below. A link to the webcast and the presentation is available from the company's homepage (www.nordicnanovector.com). Lars Nieba, interim CEO of Nordic Nanovector, said: “The management team together with the board have taken a range of actions during the last several months to increase focus, improve patient recruitment while at the same time

Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 2020

Oslo, Norge, 27. august 2020 Nordic Nanovector ASA (OSE: NANO) offentliggjør i dag sine resultater for andre kvartal og første halvår 2020. Selskapets ledelse vil gi en presentasjon av resultatene klokken 08:30 på Thon Hotel Vika Atrium i Oslo. Se ytterligere informasjon nedenfor.  "Styret og ledelsen har de siste månedene iverksatt en rekke tiltak for å sikre riktige prioriteringer og øke pasientrekrutteringen mest mulig kostnadseffektivt. Disse initiativene, sammen med den positive foreløpige analysen av PARADIGME og pågående endringer i protokollen for studien, har styrket våre

Citycon announces tenant sales increase of 11 percent in July

CITYCON OYJ   Corporate press Release 27 August 2020 at 08:00 hrs Tenant sales for Citycon increased by 11% on a total basis for the month of July compared to the same month in 2019. On a same store basis, sales increased by 8% for the same period. The average transaction size grew by 15%. The growth in sales for the month impacted the January-July results which stand at -1% for total sales and -3% for same store sales respectively. At the same time, the footfall continued to recover and was at 95 percent of prior year level in July. “Having already reported strong footfall and

Interim Report Jetpak Top Holding AB (publ) 1 January – 30 June 2020

Second Quarter: 1 April - 30 June 2020: · Total revenue decreased by -7,3 % to TSEK 203,501 (219,602),with an underlying organic growth amounting to -19,5 % · Contribution margin amounted to 29,4 % (35,8 %) · Operating profit amounted to TSEK 8,293 (25,087) · Adjusted EBITA amounted to TSEK 9,709 (25,087) · Profit for the period amounted to TSEK 4,113 (17,771) · Earnings per share was SEK 0.34 (1.48) · Cash flow from operations amounted to TSEK 32,251 (10,658) · Cash and cash equivalents amounted to TSEK 57,693 (42,390) · Net debt in relation to adjusted

Qliro Group has carried out a directed share issue of approximately SEK 210 million – the Board of Directors proposes a distribution of the shares in Qliro AB to the shareholders of Qliro Group

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR OTHER MEASURESPress release, Stockholm, 26 August 2020 Qliro Group AB (publ) (“Qliro Group” or the “Company”) (Nasdaq Stockholm: QLRO) hereby announces that the Company has carried out a directed share issue of approximately 30 million new ordinary shares, at a subscription price of SEK 7.00 per share (the “New

K-Fast Holding completes a directed new share issue of 2,000,000 B-shares, raising SEK 504 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESK-Fast Holding AB (publ) (ticker: KFAST B) (“K-Fast Holding” or the “Company”) has in accordance with the Company’s press release earlier today on 26 of August 2020 and based on the authorisation granted by the annual general meeting on 19 May 2020, resolved on

­Sale of shares in Hansa Biopharma AB (publ)

Press release Stockholm 26 August 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Nexttobe AB (“Nexttobe”) has sold 3.6 million shares in Hansa Biopharma AB (publ) ("Hansa Biopharma") through an accelerated bookbuilding to Swedish and international institutional investors at a price of SEK 240 per share (the “Share Sale”). Following the Share Sale, Nexttobe owns 2,155,379 shares in Hansa Biopharma, corresponding

The EU Commission grants conditional approval for Idefirix[TM] (imlifidase) in highly sensitized kidney transplant patients in the European Union

The conditional approval by the European Commission serves as a landmark milestone for Hansa Biopharma, as Idefirix[TM] (imlifidase) will be the Company’s first approved drug and will transform Hansa Biopharma into a commercial stage biopharmaceutical companyLund, Sweden August 26, 2020. Hansa Biopharma (“Hansa”), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the European Commission has granted conditional approval for IdefirixTM in highly sensitized kidney transplants patients. The formal approval by the European Commission was

Heimstaden Bostad successfully places EUR 650m senior unsecured bond

Heimstaden Bostad AB has today successfully completed the issue of a EUR 650 million senior unsecured bond under its EMTN programme. The bond has a maturity of 6.5 years and carries a fixed coupon of 1.375% p.a. The company intends to allocate a share of the proceeds for the repayment of short-term bank loans. Proceeds will also be used to finance the ongoing tender offer to buy back up to EUR 150 million of its outstanding EUR 500 million senior unsecured bond maturing in December 2021. All remaining proceeds will be used for general corporate purposes. Commenting on the transaction,

Nustay A/S: Publication of Half-Year Report for 2020

Nustay A/S (“Nustay”) hereby publishes its Half-Year Report for the period January – June 2020. The report is available as an attached document to this press release and on the company's website (investor.nustay.com). Below is a summary of the report.CEO Mathias Lundoe Nielsen comments: “The first half of 2020 has without a doubt been one of the toughest and most challenging periods for Nustay yet. With prolonged lockdown and travel bans, the travel industry has been one of the industries most affected by the COVID-crisis. Despite this, we have been able to further expand our product

WorkWave CEO David F. Giannetto Named a Top 50 SaaS CEO

Giannetto recognized for forward-looking approach to SaaS software leadershipHolmdel, NJ - August 26, 2020 - WorkWave [®], a provider of cloud-based software solutions that support every stage of a service business’s lifecycle, today announces that its CEO, David F. Giannetto, has been named a Top 50 SaaS CEO  by The Software Report, a comprehensive source for market research and insights, business news, investment activity and corporate actions related to the software sector. The Top 50 SaaS CEOs of

Correction: The directed new share issue comprises approximately 2 million shares

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESReferral to press release issued at 5.45 on 26 August 2020. K-Fast Holding AB (publ) (ticker: KFAST B) (“K-Fast Holding” or the “Company”) has mandated Danske Bank (The “Bookrunner”) to evaluate the conditions for carrying out a directed new share issue of

DreamHack Open Fall European RMR to Begin October 15 – Event to Offer Prize Pool Totaling $115,000

Roster Lock for All Teams in RMR, Sept. 9; Open Qualifiers, Sept. 18-20; Closed Qualifiers, Sept. 22-25; Main Event, Oct. 15-25STOCKHOLM — The DreamHack Open Fall  European Regional Major Rankings (RMR) Tournament will take place October 15-25, with a prize pool totaling $115,000.   The  all-online competition  will be a version of DreamHack’s popular Counter-Strike: Global Offensive (CS:GO) tournament. The tournament will award RMR points towards the next Valve Major.

ZUTEC REPAYS EUR1M LOAN FROM ATHANASE

Zutec Holding AB (publ) (“Zutec") today announced that it has repaid in full the loan from Athanase of EUR1m plus applicable interest. “In accordance with our intentions at the time of the rights issue we have repaid all the debt to Athanase. We believe that based on the stage of Zutec’s development that being debt free is the appropriate capital structure. We now have a strong cash position and our capital structure has been aligned and our focus is to build on the strong momentum of growth we are experiencing by making further investments into sales and marketing allowing us to

K-Fast Holding evaluates the conditions to carry out a directed new share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESK-Fast Holding AB (publ) (ticker: KFAST B) (“K-Fast Holding” or the “Company”) has mandated Danske Bank (The “Bookrunner”) to evaluate the conditions for carrying out a directed new share issue of approximately SEK 2 million, through an accelerated bookbuilding

Nexttobe announces its intention to sell shares in Hansa Biopharma AB (publ)

Press release Stockholm 26 August 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Carnegie Investment Bank AB (“Carnegie”) has been retained to explore the opportunity to sell approximately 3.6 million shares, corresponding to approximately 7.8% of total shares and 8.1% of total votes outstanding in Hansa Biopharma AB (“Hansa Biopharma”) to Swedish and international institutional

#20-298 Delisting of certain Derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-297 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 30 500 treasury shares on 26 August 2020. The shares were purchased at an average price of price of NOK 53.2097. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 546 892 treasury shares.  Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no   Selvaag Bolig ASA is a residential property developer which controls the entire value chain from acquisition of land to sale of turnkey homes. The company has several thousand

There are no items matching the current filter
There are no more items matching the current filter
Back to top